for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover The Tan Sheet
  [0 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 1530-1206
   Published by Informa plc Homepage  [16 journals]
  • US Advertising Roundup: Benefiber Claim Appeal Fails,
           Native Remedies Pulls Product
    • Abstract: NARB rejects GSK/Novartis argument on Benefiber claims; and another Silver Star Brands' brand pulls a product during NAD review.
      PubDate: Thu, 28 Jan 2016 00:05:01 -050
       
  • Supplement Claims On Duration Of Cold, Menopausal Support Fail In UK
           Reviews
    • Abstract: The Advertising Standards Authority says Swedish firm Enymatica misses the mark for supporting ColdZyme supplement claims and UK firm PharmaCare’s ads for the Promensil menopause symptoms supplement run afoul of the rule it cites as support.
      PubDate: Thu, 28 Jan 2016 00:00:57 -050
       
  • J&J Heralds Year Of 'Good Momentum' For Consumer Health Business
    • Abstract: J&J says following a year of innovation, 2016 will be a year of growth for its consumer business on the return of more recalled OTC brands and strong positioning in consumers' emerging self-care trend. The firm reports consumer division sales in 2015 slipped 6.8%, with a 9.5% drag from foreign currency exchange.
      PubDate: Wed, 27 Jan 2016 00:05:01 -050
       
  • P&G Omits Health Care From 'Particular Priority' In
           'Transformation'
    • Abstract: CFO Jon Moeller drives home that P&G is "operating in a more volatile environment than we ever have" as it continues shedding slow-growth brands and that the firm gives "particular priority" to spurring growth in categories other than health care.
      PubDate: Wed, 27 Jan 2016 00:00:11 -050
       
  • Swanson Health Sale Could Lead Private Equity Spike In Supplement Space
    • Abstract: Swander Pace Capital's Swanson Health deal announced Jan. 25 is the firm's second in two months in the supplement industry after acquiring Captek Softgel in December. OTC drug and supplement firms in 2016 could be among the consumer product spaces targeted in likely higher private equity investing.
      PubDate: Tue, 26 Jan 2016 00:05:01 -050
       
  • Old Spice Hardest Working
           Campaign Reflects P&G Focus On Core Brands
    • Abstract: P&G launches the Old Spice Hardest Working Collection line of antiperspirants/deodorants with a higher level of the brand’s beta-cyclodextrin odor-fighting technology. The line, also including a body wash, is supported with a campaign featuring a new spokesperson, "Legendary Man."
      PubDate: Tue, 26 Jan 2016 00:00:02 -050
       
  • Weekly Trademark Review Jan. 19, 2016
    • Abstract: OTC drug, personal care product and nutritional supplement trademark filings compiled by “The Tan Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.
      PubDate: Mon, 25 Jan 2016 00:04:10 -050
       
  • Merck US Versus Merck Germany: Trademark War Heats Up
    • Abstract: US Merck alleges "false advertising, deceptive trade practices, cybersquatting and breach of contract" in complaint that follows German Merck's decision to rebrand itself in the lead up to new CEO Stefan Oschmann taking the top job in April 2016
      PubDate: Mon, 25 Jan 2016 00:04:03 -050
       
  • Supplement Market Regulatory Forecasts Vary From Stormy To Quiet
    • Abstract: The potential for legislation from Senators Durbin and Blumenthal d to tighten supplement industry regulation and for additional enforcement activity by FDA and DoJ as well as by state authorities are prominent on trade groups' radars for 2016.
      PubDate: Mon, 25 Jan 2016 00:03:58 -050
       
  • Patience Factors In OTC Drug Regulatory Outlook
    • Abstract: Even as drug industry stakeholders submit comments on FDA proposals and other communications, such as the agency's November draft guidances on Sunscreen Innovation Act compliance, they do not estimate the length of the wait for results.
      PubDate: Mon, 25 Jan 2016 00:01:15 -050
       
  • FDA Finds Morphine-Spiked Herbal Cough Syrup In Chinese Firm's Plant
    • Abstract: The finding of morphine in a consumer health product made in China could rekindle concerns about lapses in supply chain security previously linked to drugs and adulterants or contaminants found in other imported FDA-regulated products.
      PubDate: Mon, 25 Jan 2016 00:00:36 -050
       
  • Energy And Commerce Members Want FDA Overseas Operations Update
    • Abstract: The GAO will report on foreign office closures and risk-based inspection policy amid Energy and Commerce leaders' concerns that unequal playing field remains.
      PubDate: Mon, 25 Jan 2016 00:00:29 -050
       
  • FDA Posts Investigator In Singapore, But Trims Foreign Office List
    • Abstract: FDA's Office of International Programs consolidates its China offices to "strategically focus its resources." FDA shifts away from primarily a domestic focus to global as drug criminal organizations spread globally
      PubDate: Mon, 25 Jan 2016 00:00:21 -050
       
  • CHPA, PCPC Urge Stretching Sunscreen Ingredient Safety Data Net
    • Abstract: CHPA and PCPC submit comments to FDA on Sunscreen Innovation Act compliance draft guidances. The groups ask the agency to expand the categories of data sufficient to support sunscreen ingredients as GRASE and suggest augmenting NDAC deliberations with input from toxicologists and biologists.
      PubDate: Fri, 22 Jan 2016 00:05:02 -050
       
  • Consumer Health New Products Roundup: BPI, Amazing Grass, TNT
    • Abstract: BPI licenses ChromaDex ingredient; bmiSmart's I- line debuts; Intelligent Labs offers Ultra Pure Omega 3; and more news in brief.
      PubDate: Fri, 22 Jan 2016 00:00:02 -050
       
  • ProPhase Enters Direct-Response Supplement Sales To Cure Seasonal Slumps
    • Abstract: The marketer of the Cold-EEZE cold remedy line enters the supplement market with LegendzXL "to offset the seasonality of our revenues and our dependence on the severity of the cold season." The supplement contains a proprietary formulation for "supporting physical readiness, energy and relieving stress."
      PubDate: Thu, 21 Jan 2016 00:00:05 -050
       
  • Industry Roundup: Cough Syrup Import Alert, J&J Supreme Court
           Petition
    • Abstract: Import alert on morphine-spiked cough syrup; and Supreme Court denies J&J petition in Motrin litigation.
      PubDate: Wed, 20 Jan 2016 00:05:01 -050
       
  • More Warnings Show Own-Label Supplement Firms Slow On GMP Uptake
    • Abstract: Misbranding due to incorrect dosing information on labels also noted in warning letters FDA posts on Jan. 19 to Alkebulan International, Nutraloid Labs, Nutrafill and Perfect Water and Essentials.
      PubDate: Wed, 20 Jan 2016 00:00:02 -050
       
  • India Plans To End Dependence On China Bulk Imports By 2020
    • Abstract: India says it is aiming to end its dependence on Chinese bulk drug imports by 2020 as it announces plans to set up a string of pharmaceutical industrial parks to boost manufacturing capacity.
      PubDate: Mon, 18 Jan 2016 00:02:31 -050
       
  • Weekly Trademark Review Jan. 12, 2016
    • Abstract: OTC drug, personal care product and nutritional supplement trademark filings compiled by “The Tan Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.
      PubDate: Mon, 18 Jan 2016 00:01:49 -050
       
  • CHPA Looks For FDA Reform Legislation To Deliver Monograph Changes In 2016
    • Abstract: CHPA chief Scott Melville is optimistic for OTC monograph reform progress in 2016 following. In an interview about CHPA's 2016 priorities, Melville also said state and local environmental regulations that touch OTC drugs will garner attention.
      PubDate: Mon, 18 Jan 2016 00:01:41 -050
       
  • P&G Asks For Higher Class Action Floor In
           Align Class Certification Appeal
    • Abstract: Procter & Gamble petitions the Supreme Court to overturn a decision giving class action certification to a complaint alleging the firm deceived consumers with its “snake oil” Align probiotic. If the court overturns the lower court, the action could make class action certifications more difficult.
      PubDate: Mon, 18 Jan 2016 00:01:24 -050
       
  • Business & Finance Roundup: Bayer, NutraFuels, Symrise
    • Abstract: Bayer expands manufacturing in China; Florida supplement firms merge; and more news in brief.
      PubDate: Mon, 18 Jan 2016 00:00:22 -050
       
  • Continued Quality Push Among China's 2016 Regulatory Trends To Watch
    • Abstract: The China pharma market in 2015 was marked by a drastic market slowdown and turbulent regulatory headwinds. But looking ahead, analysts say while challenges remain, some important breakthroughs could be on the way.
      PubDate: Mon, 18 Jan 2016 00:00:00 -050
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015